COMMUNIQUÉS West-GlobeNewswire

Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
30/07/2026
Company to Host Conference Call with Live Q&A, August 13, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – July 30, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, [...]
Voting Rights and Shares Capital of the Company
30/07/2026
PARIS, July 30, 2026 (GLOBE NEWSWIRE) -- In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés [...]
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
30/07/2026
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT SOUTH SAN FRANCISCO, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical [...]
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
30/07/2026
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod Company remains on track to submit its first New Drug Application for obefazimod for the treatment of moderately to severely active ulcerative [...]
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
30/07/2026
LEXINGTON, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a [...]
Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability
30/07/2026
Highl ights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is engaging payers and [...]
Spineway : H1 2026 results
30/07/2026
H1 2026 results Continued growth Stable results Strong embedded growth drivers Issuance of straight bonds to finance future growth In thousands of euros Consolidated financial statements – Unaudited H1 2026 H1 2025 [...]
SRX Global Acquires Shares in Jersey Mike’s $1 Billion Initial Public Offering
30/07/2026
NORTH PALM BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments [...]
Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026)
30/07/2026
Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026) Attachment 2026 Half-year Financial Report_Ipsen S.A.
Siemens Healthineers Appoints João Seabra President and Head of the Americas
30/07/2026
Erlangen, Germany, July 30, 2026 (GLOBE NEWSWIRE) -- João Seabra, head of Siemens Healthineers Enterprise Services, is appointed President and Head of the Americas for Siemens Healthineers, effective Oct. 1, 2026, [...]
SPINEWAY : Résultats semestriels 2026
30/07/2026
Ecully, le 30 juillet 2026 –19h Résultats semestriels 2026 Poursuite de la croissance Stabilité des résultats Solides relais de croissance embarqués Émission d’obligations simples pour financer le développement En [...]
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
30/07/2026
WASHINGTON, July 30, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP, SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company that develops and commercializes new medicines for vector- [...]
HAIR LOSS AWARENESS MONTH 2026: The Future of Hair Restoration Has Arrived
30/07/2026
Dr. Alan J. Bauman, board-certified Hair Restoration Physician and founder of Bauman Medical, at the practice's Boca Raton, FL Hair Hospital. Bauman Medical Highlights the New Era of AI Diagnostics, Regenerative [...]
Ipsen S.A. publie son Rapport financier semestriel 2026 (semestre clos le 30 juin 2026)
30/07/2026
Ipsen S.A. publie son Rapport financier semestriel 2026 (semestre clos le 30 juin 2026) Pièce jointe 2026 Rapport semestriel_Ipsen S.A.
Diakonos Oncology Announces First Patients Dosed in Phase 1/2 DOC-RM Study of DOC1021 in Refractory Melanoma
30/07/2026
First patients dosed at City of Hope and the University of Alabama at Birmingham DOC-RM recently featured as a Trial-in-Progress presentation at the 2026 ASCO Annual Meeting FDA Fast Track designation granted for [...]
Communiqué de presse : Rapport financier semestriel 2026 de Sanofi
30/07/2026
Rapport financier semestriel 2026 de Sanofi Paris, le 30 juillet 2026 . Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son rapport financier [...]
IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer
30/07/2026
Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company’s large, randomized Phase II study, OVATION 2 Strong enrollment [...]
Applied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™
30/07/2026
Manufacturing milestone supports planned clinical development of the Company’s lead investigational biologic for chronic wounds SCOTTSDALE, Ariz., July 30, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical [...]
Press Release: Sanofi’s half-year financial report for 2026
30/07/2026
Sanofi’s half-year financial report for 2026 Paris, July 30, 2026 . Sanofi announces that its half-year financial report for the period ending June 30, 2026, is now available online and has been filed with the French [...]

Pages